Artemis Medicare Services: Monitoring Agency Report for Q1FY27 Released
Artemis Medicare Services Limited's Monitoring Agency Report for Q1FY27 shows utilization of ₹17.45 crore from its ₹330 crore preferential issue. Funds were used for medical equipment and hospital construction. Unutilized proceeds of ₹175.66 crore are in fixed deposits. The utilization timeline has been extended to November 15, 2027.
This is a standard quarterly compliance report regarding the utilization of funds from a past preferential issue and does not introduce new material information that would significantly impact the company's stock or operations.
The report is a routine compliance filing and does not contain any new financial performance data or significant business updates that would sway sentiment.
Artemis Medicare Services Limited has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report, issued by CARE Ratings Limited, details the utilization of proceeds from a preferential issue amounting to ₹330 crore. During the first quarter of FY27 (April 1 to June 30, 2026), the company utilized ₹17.45 crore for capital expenditure requirements. This included ₹16.96 crore for procuring medical equipment for its Raipur hospital and ₹0.49 crore for the construction of VIMHANS Hospital in Delhi.
As of June 30, 2026, the total unutilized amount from the preferential issue stands at ₹175.66 crore. These unutilized funds have been deployed in fixed deposits with various banks, including HDFC Bank, ICICI Bank, and Axis Bank, with maturity dates extending up to May 2027. The total interest earned on these deposits during the quarter was ₹3.74 crore.
The original timeline for utilizing the proceeds for acquisition, expansion, and capital expenditure was May 15, 2026. However, this timeline has been extended to November 15, 2027, as per a Board resolution dated May 08, 2026. The company confirmed that all utilization is in line with the disclosures made in the Offer Document, with no material deviations observed.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.